UBS Group »

Cyclerion Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Cyclerion Therapeutics (CYCN) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Cyclerion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyclerion Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclerion Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.1k 2.5k 3.20
2023-12-31 $7.5k 2.2k 3.35
2023-09-30 $943 276 3.42
2023-06-30 $766 186 4.12